Philippines Peptides LogoPhilippines Peptides
Peptide Field Reference

MOTS-c

Mitochondrial-derived peptide — the exercise mimetic that optimizes metabolism, insulin sensitivity, and longevity.

Category

Longevity & Energy

Frequency

3–5x weekly

Research

Phase 1 Clinical Trials

§ 01

What is MOTS-c

MOTS-c (Mitochondrial Open reading frame of the 12S rRNA type-c) is a peptide encoded within the mitochondrial genome — making it one of the few known mitochondria-derived peptides. It was discovered in 2015 and is a subject of intense longevity research for its role in metabolic regulation and stress resistance. Browse the full peptide library for related longevity compounds.

MOTS-c is often called an 'exercise mimetic' because it activates many of the same cellular pathways that are triggered by physical exercise — including AMPK activation, improved insulin sensitivity, and mitochondrial biogenesis. For cellular energy support, it stacks well with NAD+. Studies in elderly mice showed dramatic improvements in exercise capacity and metabolism when given MOTS-c.

What makes MOTS-c uniquely interesting for longevity is that it is a retrograde signal from the mitochondria (the powerhouses of the cell) to the nucleus — a form of cellular communication that declines with age. For telomere extension, consider combining with Epitalon. Supplementing MOTS-c may help restore this critical signaling pathway. Longevity stacks often combine MOTS-c with thymosin alpha-1 to address both metabolic and immune aspects of aging.

§ 02

How it works

AMPK Activation: MOTS-c activates AMPK (AMP-activated protein kinase), the master metabolic sensor of the cell. AMPK activation improves insulin sensitivity, promotes fat oxidation, and mimics the effects of caloric restriction.

FOXO Pathway: MOTS-c activates FOXO transcription factors, which regulate longevity genes and stress resistance pathways.

Mitochondrial Biogenesis: MOTS-c promotes the formation of new mitochondria, improving cellular energy capacity and metabolic efficiency.

Nuclear Translocation: Uniquely, MOTS-c can translocate from the mitochondria to the cell nucleus during stress, where it directly regulates gene expression.

PH

On the ground in the Philippines

MOTS-c was discovered by Pinchas Cohen and Changhan Lee at USC's Leonard Davis School of Gerontology in 2015. It is not registered with FDA Philippines and there's no licensed prescribing route. The supply here is research-grade lyophilized powder routed through compounding suppliers or personal import — typical of a peptide where the human Phase 1 work is recent and the longevity-research community is the primary user base.

The Filipino metabolic context makes MOTS-c interesting on paper: insulin resistance and prediabetes are pervasive in Manila, white-rice-heavy meals dominate, and Type 2 diabetes prevalence sits around 6–7% nationally. The exercise-mimetic angle is also hard to overstate — Manila traffic and heat genuinely suppress activity for a lot of professionals working in BGC and Makati, and aerobic capacity at 35 is often what you'd expect at 50 elsewhere. None of this means MOTS-c replaces walking and lifting; it does mean baseline AMPK signaling is probably already compromised in the typical user here.

BGC condo reconstitution workflow: a 10mg vial reconstituted in 2mL BAC water gives 5mg per 1mL = 50 units on a U-100 syringe = 5mg dose. SC injection 3–5x weekly. Storage in Manila heat is the bottleneck — refrigerate at 2–8°C, transport in an insulated pouch, and discard at 14 days reconstituted. Hi-Precision and Makati Med run the bloodwork that matters here: fasted glucose, HbA1c, fasted insulin (for HOMA-IR calculation), and a lipid panel pre/post 8-week cycle.

Hospitals · prescription routes

  • Makati Medical CenterMakati
  • St. Luke's BGCBGC
  • The Medical CityPasig
  • Asian HospitalAlabang

Pharmacies · branches with confirmed stock

  • Mercury DrugNationwide
  • WatsonsNationwide

Real PH pricing · observed

  • MOTS-c 10mg vial (research-grade)₱4,200–5,500$75–98
  • BAC water 30mL₱350–500$6–9
  • Insulin syringes 31g (box of 100)₱650–900$12–16
  • Fasted insulin + HbA1c + lipid panel₱2,800–3,800$50–68
  • OGTT (oral glucose tolerance test)₱1,800–2,500$32–45

Customs · Import reality

MOTS-c clears BOC at single-vial volumes as research peptide without intervention in most cases. The 10mg vials ship dry and travel well; cold-chain through Singapore or Hong Kong forwarders is standard. Most BGC longevity-stack users replenish every 6 weeks rather than stockpiling, given Manila weather risk on multi-vial parcels held at customs.

§ 03

Reported benefits

  • 01Improved insulin sensitivity and blood glucose regulation
  • 02Enhanced fat oxidation and metabolic efficiency
  • 03Exercise mimetic effects (activates exercise pathways)
  • 04Improved muscle endurance and physical performance
  • 05Longevity pathway activation (AMPK, FOXO)
  • 06Potential obesity prevention
  • 07Anti-inflammatory effects
  • 08Neuroprotective properties
§ 04

Dosing protocol

Suggested titration
PhaseDoseFrequencyDuration
Standard5mg3–5x weekly SC8 weeks
Cycle5mg3x weekly8 weeks on, 4 off

Always start at the lowest effective dose and titrate up gradually.

§ 05

Side effects

Common

  • Generally very well tolerated in studies
  • Mild injection site reaction
  • Possible increased appetite (metabolic activation)

Rare

  • ·Hypoglycemia in fasted state at high doses
§ 06

Who should not use MOTS-c

§ 07

What to expect

Week 1–2

Improved energy and endurance during exercise. Blood sugar levels may stabilize.

Week 3–6

Noticeable metabolic improvements. Better body composition. Improved exercise recovery.

Month 2–3

Full metabolic benefits realized. Stacks well with caloric restriction or fasting protocols.

§ 08

FAQ

Q-01

Can MOTS-c replace exercise?

No — it is an exercise mimetic, meaning it activates some of the same pathways as exercise. But exercise has many more effects beyond metabolic signaling. MOTS-c is a complement to, not a replacement for, physical activity.

Q-02

How does MOTS-c differ from NAD+?

Both support mitochondrial function but through different mechanisms. NAD+ provides the fuel (electron carrier). MOTS-c sends the signaling message from mitochondria to the nucleus. They are complementary and commonly stacked. Source from the community-verified supplier list. For clinics and protocols specific to Philippines, see the NAD+ therapy guide.

§ 09

Where to get MOTS-c in the Philippines

See our community-verified supplier list with COA verification and cold-chain shipping to the Philippines.

10

Primary sources

Citations supporting the clinical claims on this page. Each entry links to the primary record.

  1. [01]

    MOTS-c discovery — Lee 2015

    Mechanism

    Lee C, Zeng J, Drew BG, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metab 2015;21(3):443–454.

    DOI: 10.1016/j.cmet.2015.02.009
  2. [02]

    MOTS-c as exercise-induced regulator — Reynolds 2021

    Mechanism

    Reynolds JC, Lai RW, Woodhead JST, et al. "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis." Nat Commun 2021;12:470.

    DOI: 10.1038/s41467-020-20790-0
  3. [03]

    MOTS-c and adipose thermogenesis — Lu 2019

    Mechanism

    Lu H, Tang S, Xue C, et al. "Mitochondrial-derived peptide MOTS-c increases adipose thermogenic activation to promote cold adaptation." Front Endocrinol 2019;10:858.

    DOI: 10.3389/fendo.2019.00858
  4. [04]

    MOTS-c nuclear translocation — Kim 2018

    Mechanism

    Kim KH, Son JM, Benayoun BA, Lee C. "The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress." Cell Metab 2018;28(3):516–524.

    DOI: 10.1016/j.cmet.2018.06.008
  5. [05]

    FDA Philippines drug registry — MOTS-c not listed

    Reference

    FDA Philippines Registered Drug Products Database. Verified 2026-05-07: MOTS-c has no Philippine drug registration; available only as research-grade peptide.

    Source

Risk · Disclosure · Editorial Status

This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.

In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.

Editorial Status

Independent · Non-clinical

Affiliation

Not a clinic · Not a pharmacy

Last Updated

May 7, 2026

Related peptides